Epidemiology context: Antimicrobial effect of Synercid®;Contexte épidémiologique: Intérêt microbiologique de Synercid®

Presse Medicale

Volumn 30, Issue 25 II, 2001, Pages

  Etienne, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; QUINUPRISTIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; NONHUMAN; PHENOTYPE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; GRAM-POSITIVE BACTERIAL INFECTIONS; GRAM-POSITIVE COCCI; HUMANS; MICROBIAL SENSITIVITY TESTS; VIRGINIAMYCIN;

EID: 0035828292     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Inhibition of protein synthesis by streptogramins and related antibiotics
2. Antimicrobial activity of quinupristin/dalfopristin tested against over 28000 recent clinical isolates from 200 medical centers in the United States and Canada
3. Comparative antibiotic activity versus vancomycin intermediate-susceptible Staphylococcus aureus
4. In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin/dalfopristin against staphylococci and enterococci, including vancomycin- intermediate and -resistant strains
5. Resistance aux macrolides, lincosamides, steptogramines, Précis de bactériologie clinique
6. Characterization of isolates associated with emerging resistance to quinupristin/dalfopristin (Synercid®) during a worldwide clinical program
7. Distribution of genes encoding resistance to macrolides, lincosamides and streptogramins among staphylococci
8. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium